atenolol has been researched along with Craniofacial Pain in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira-Fusaro, MC | 1 |
| Clemente-Napimoga, JT | 1 |
| Teixeira, JM | 1 |
| Torres-Chávez, KE | 1 |
| Parada, CA | 1 |
| Tambeli, CH | 1 |
| Chichorro, JG | 1 |
| Lorenzetti, BB | 1 |
| Zampronio, AR | 1 |
2 other studies available for atenolol and Craniofacial Pain
| Article | Year |
|---|---|
5-HT induces temporomandibular joint nociception in rats through the local release of inflammatory mediators and activation of local β adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroi | 2012 |
Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats.
Topics: Animals; Arachidonic Acids; Atenolol; Behavior, Animal; Biogenic Amines; Bradykinin; Bradykinin B1 R | 2004 |